Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder*
β Scribed by Rupnow, Marcia F. T.; Greenspan, Andrew; Gharabawi, Georges M.; Kosik-Gonzalez, Colette; Zhu, Young; Stahl, Stephen M.
- Book ID
- 111860462
- Publisher
- Informa plc
- Year
- 2007
- Tongue
- English
- Weight
- 387 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0300-7995
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acuteβphase data from a subset of patients (β₯65 years) with GAD were pooled from four randomized, doubleβblind, placeboβcontrolled trials of dulo
Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with